Urokinase plasminogen activator receptor

Mahdi F, Shariat-Madar Z, Todd RF 3rd, Figueroa CD, Schmaier AH Expression and colocahzation of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells. Blood 2001 97 2342-2350. 56... 

Llinas P, Le Du MH, Gardsvoll H, Dano K, Ploug M, Gilquin B, et al. Crystal structure of the human urokinase plasminogen activator receptor bound to an antagonist peptide. EMBO J 2005 24(9) 1655-1663. 

Almasi CE, Hoyer-Hansen G, Christensen IJ, Dano K, Pappot H. Prognostic impact of liberated domain I of the urokinase plasminogen activator receptor in squamous cell lung cancer tissue. Lung Cancer 2005 48(3) 349-355. 

Riisbro R, Christensen IJ, Piironen T, Greenall M, Larsen B, Stephens RW, et al. Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer. Clin Cancer Res 2002 8(5) 1132—1141. 

Perch M, Kofoed P, Fischer TK, Co F, Rombo L, Aaby P, et al. Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection. Parasite Immunol 2004 26(5) 207-211. 

Bohuslav J, Horejsi V, Hansmann C, Stockl J, Weidle UH, Majdic O, et al. Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes. J Exp Med 1995 181(4) 1381—1390. 

Mizukami IF, Faulkner NE, Gyetko MR, Sitrin RG, Todd RF, III. Enzyme-linked immunoabsorbent assay detection of a soluble form of urokinase plasminogen activator receptor in vivo. Blood 1995 86(1) 203-211. 

Pappot H, Hoyer-Hansen G, Ronne E, Hansen HH, Brunner N, Dano K, et al. Elevated plasma levels of urokinase plasminogen activator receptor in non-small cell lung cancer patients. Eur J Cancer 1997 33(6) 867-872. 

Riisbro R, Stephens RW, Brunner N, Christensen IJ, Nielsen HJ, Heilmann L, et al. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases. Gynecol Oncol 2001 82(3) 523-531. 

Begum FD, Hogdall CK, Kjaer SK, Christensen L, Blaakaer J, Bock JE, et al. The prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) levels in stage III ovarian cancer patients. Anticancer Res 2004 24(3b) 1981-1985. 

Speth C, Pichler I, Stockl G, Mair M, Dierich MP. Urokinase plasminogen activator receptor (uPAR CD87) expression on monocytic cells and T cells is modulated by HIV-1 infection. Immunobiology 1998 199(1) 152 162. 

Slot O, Brunner N, Locht H, Oxholm P, Stephens RW. Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders Increased concentrations in rheumatoid arthritis. Ann Rheum Dis 1999 58(8) 488-492. 

E9. Evans, C. P., Elfman, F., Parangi, S., Conn, M., Cunha, G., and Shuman, M. A., Inhibition of prostate cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade. Cancer Res. 57, 3594-3599 (1997). 

Duggan C, Maguire T, McDermott E, et al. Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer. Int J Cancer 1995 29 597-600. 

V., Plasminogen- and colony-stimulating factor-1 associated markers in bladder carcinoma Diagnostic value of urokinase plasminogen activator receptor and plasminogen activator inhibitor type-2 using immunocytochemical analysis. Urol. Res. 30, 301-309 (2002). 

Jl. Jensen, M. K., Riisbro, R., Holten-Andersen, M. N., et al.. Collagen metabolism and enzymes of the urokinase plasminogen activator system in chronic myeloproliferative disorders Correlation between plasma-soluble urokinase plasminogen activator receptor and serum markers for collagen metabolism. Eur. J. Haematol. 71, 276-282 (2003). 

Wang M, Lowik DWPM, Miller AD et al (2009) Targeting the urokinase plasminogen activator receptor with synthetic self-assembly nanoparticles. Bioconjug Chem 20 32 0... 

Urokinase plasminogen activator receptor (CD87) something old, something new. Laboratory Hematology, 9, 67-71. 

Drapkin PT, O RiordanCR, Yi SM, Chiorini JA, CardellaJ, Zabner J, Welsh MJ. Taigeting the urokinase plasminogen activator receptor enhances gene transfer to human airway epithelia. J Clin Invest 2000 105 589-596. 

---